Definium Therapeutics Inc (DFTX) PT Raised to $60 at Stifel

July 7, 2026 4:32 PM

Stifel analyst Paul Matteis raised the price target on Definium Therapeutics Inc (NASDAQ: DFTX) to $60.00 (from $30.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found